FANCA:用于白血病早期预测的计算机模拟有害突变分析
FANCA: In-Silico deleterious mutation analysis for early prediction of leukemia
摘要:
FANCA是Fanconi贫血互补群(Fanconi anemia complementation group,FANC)家族中的一种新的生物标志物,是白血病的抗原。FANCA的过度表达预测了世界上第二大常见癌症,它是癌症相关死亡的原因。非同义SNP是导致编码多肽改变的一组必需的SNP。基因产物的氨基酸序列的改变导致白血病。首先,我们研究了FANCA编码区中的单个SNP和计算工具,如PROVEAN,PolyPhen 2,MuPro和PANTHER,以计算有害突变评分。使用I-TASSER进行三维结构和功能预测。此外,使用GlaxyWeb工具对预测的结构进行了细化。在这项研究中,蛋白质组数据已从UniProtKB检索。数据集的编码区包含100个非同义单核苷酸多态性(nsSNP),并且24个错义SNP已被所有分析确定为有害的。在这项工作中,使用了六种众所周知的计算工具来研究白血病相关的nsSNP。推测这些nsSNPs可能在FANCA的上调中发挥作用,这进一步导致引发白血病进展。目前的研究将有利于研究人员和从业人员处理与FANCA相关的癌症相关疾病。拟议的研究还将有助于在药物发现领域发展精准医学。
英文摘要:
As a novel biomarker from the Fanconi anemia complementation group (FANC) family, FANCA is antigens to Leukemia cancer. The overexpression of FANCA has predicted the second most common cancer in the world that is responsible for cancer-related deaths. Non-synonymous SNPs are an essential group of SNPs that lead to alterations in encoded polypeptides. Changes in the amino acid sequences of gene products lead to Leukemia. First, we study individual SNPs in the coding region of FANCA and computational tools like PROVEAN, PolyPhen2, MuPro, and PANTHER to compute deleterious mutation scores. The three-dimensional structural and functional prediction conducted using I-TASSER. Further, the predicted structure refined using the GlaxyWeb tool. In the study, the proteomic data has been retrieved from the UniProtKB. The coding region of the dataset contains 100 non-synonymous single nucleotide polymorphisms (nsSNPs), and 24 missense SNPs have been determined as deleterious by all analyses. In this work, six well-known computational tools were employed to study Leukemia-associated nsSNPs. It is inferred that these nsSNPs could play their role in the up-regulation of FANCA, which further leads to provoke leukemia advancement. The current research would benefit researchers and practitioners in handling cancer-associated diseases related to FANCA. The proposed study would also help to develop precision medicine in the field of drug discovery.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。